|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Prelude Therapeutics (NASDAQ: PRLD) through any online brokerage.
There are no as such competitors for Prelude Therapeutics.
The latest price target for Prelude Therapeutics (NASDAQ: PRLD) was reported by HC Wainwright & Co. on 2021-04-26. The analyst firm set a price target for 62.00 expecting PRLD to rise to within 12 months (a possible 49.00% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Prelude Therapeutics (NASDAQ: PRLD) is $41.61 last updated Fri May 07 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Prelude Therapeutics.
There is no upcoming split for Prelude Therapeutics.